Research on the Intervention of Virtual Reality Technology Based on TCM Syndrome Differentiation on Cardiovascular Severe Diseases
Phase 1
Recruiting
- Conditions
- Severe cardiovascular disease
- Registration Number
- ITMCTR2100004412
- Lead Sponsor
- The Second Affiliated Hospital of Zhejiang Chinese Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients with severe cardiovascular diseases (mainly including acute heart failure, unstable angina pectoris, acute non ST segment elevation myocardial infarction and hypertension subacute) in our hospital from October 2020 to January 2021;
2. Patients aged 40-80 years;
3. Patients receiving VR treatment within 48 hours after admission.
Exclusion Criteria
1. Patients with cardiogenic shock;
2. Patients with malignant arrhythmia;
3. Patients with acute ST segment elevation myocardial infarction.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Catecholamine;
- Secondary Outcome Measures
Name Time Method